Reading through the PIQ announcement 23/4/15, one would assume that PIQ revenues from the A2 Milk contract would rise commensurate with the increase in A2 Milk production volumes. Testing is conducted daily. With established revenues circa $1 mill p.a. and growing 27% year on year it would not surprise to see a significant increase in PIQ revenue.
“We are delighted to enter in to this contract with The a2 Milk Company to analyse the protein
composition of their premium dairy products.Truth-in-labelling is an area of growing consumer
concern and the ability to work with such a high-end company with a clear focus on delivering a unique, high-quality product provides further validation of our global, market leading analytics capabilities. The a2 Milk Company represents an ideal client for PILL and we look forward to working with them in a collaborative fashion to help them deliver a consistent high-quality product moving forward.”
No doubt we are awaiting the impending Pharma Deals re the Diagnostics however, revenue from the analytical services shouldn't be underestimated.
PIQ Price at posting:
33.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)